Betahistine Other names: Betahistine hydrochloride

Chemical formula: C₈H₁₂N₂  Molecular mass: 136.194 g/mol  PubChem compound: 2366

Active ingredient description

Betahistine dihydrochloride is a histamine-like drug in which pharmacological activity can be attributed to a specific effects and/or more direct influences on recovery mechanisms the vestibular nuclei. It has weak agonist activity at histamine H1 receptors and moderate antagonist activity at H3 receptors. Betahistine may increase blood flow to the cochlear region as well as to the whole brain.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N07CA01 Betahistine N Nervous system → N07 Other nervous system drugs → N07C Antivertigo preparations → N07CA Antivertigo preparations
Discover more medicines within N07CA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
BETAHISTINE DIHYDROCHLORIDE Tablets Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 54856-23-4
CAS Substance: 5579-84-0
CAS Substance: 5638-76-6
DrugBank Drug: DB06698
KEGG Drug: D07522
PubChem Compound: 2366
RxNorm Ingredient: 1511
SNOMED-CT Concept: 418067008
Betahistine (substance)
UNII Identifier: 49K58SMZ7U
BETAHISTINE HYDROCHLORIDE
UNII Identifier: X32KK4201D
BETAHISTINE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.